(Q43658192)

English

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

F R Hirsch

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

K Osterlind

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

N Jeppesen

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P Dombernowsky

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S Ingeberg

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P G Sorensen

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

C Kristensen

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H H Hansen

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

647-653

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Incidence of lung cancer in Denmark: historical and actual status

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of small-cell cancer of the lung

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Current status of etoposide in the management of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of small cell lung cancer: current state of the art.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic stem cell transplantation for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy: is it standard management for any common solid tumor?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Combining cisplatin and carboplatin complementary or contradictory?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011132014518

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1011132014518

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43658192&oldid=2102362250"